News
New asthma drug approved on NHS branded a ‘wonder drug’
NICE has issued a Final Appraisal Determination (FAD) recommending dupilumab as an add-on maintenance treatment for severe asthma.
You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.
NICE has issued a Final Appraisal Determination (FAD) recommending dupilumab as an add-on maintenance treatment for severe asthma.